European Pharma - EMA Healthcare and Drug Approvals | European Drug Approvals News

top of page

iPharmaCenter

Global | Comprehensive | Patient Centric

Home
COVID-19
News
Conferences
Healthcare Policies
Regional News
Patient info
Contact
More

Use tab to navigate through the menu items.

All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News

Search

NICE ASSESSMENT OUTCOMES | United Kingdom | Healthcare | Pharma | News | Blogs | iPharmaCenter

ipharmaservices

7 days ago

NICE ASSESSMENT OUTCOMES | United Kingdom | Healthcare | Pharma | News | Blogs | iPharmaCenter

Drug approvals in Europe| EMA drug approvals in 2022 | 2023 |European Commission News| iPharmaCenter

ipharmaservices

7 days ago

Drug approvals in Europe| EMA drug approvals in 2022 | 2023 |European Commission News| iPharmaCenter

France healthcare News | HAS Sante | COVID 19 | Drug approvals | iPharmaCenter

ipharmaservices

Jan 6

France healthcare News | HAS Sante | COVID 19 | Drug approvals | iPharmaCenter

COVID19 drug updates | FDA EMA approved COVID19 drugs

ipharmaservices

Oct 9, 2022

COVID19 drug updates | FDA EMA approved COVID19 drugs

ipharmaservices

Sep 19, 2022

Opdualag was approved for unresectable/metastatic melanoma | LAG-3 inhibitors | Mode of action

2023 | 2022 | CHMP Positive Opinions | EMA Drug Approvals | European Commission | Pharma | News

ipharmaservices

Sep 16, 2022

2023 | 2022 | CHMP Positive Opinions | EMA Drug Approvals | European Commission | Pharma | News

European Commission approved Scemblix for chronic myeloid leukemia | iPharmaCenter

ipharmaservices

Aug 29, 2022

European Commission approved Scemblix for chronic myeloid leukemia | iPharmaCenter

HAS ASSESSMENT OUTCOMES | FRANCE PHARMA NEWS

ipharmaservices

Jun 30, 2022

HAS ASSESSMENT OUTCOMES | FRANCE PHARMA NEWS

Roche’s Polivy was approved as first-line therapy for patients with DLBCL.

ipharmaservices

May 25, 2022

Roche’s Polivy was approved as first-line therapy for patients with DLBCL.

FDA gave the nod to Pfizer's Paxlovid | Pfizer to supply 2.5 million doses of Paxlovid to the UK

ipharmaservices

Dec 23, 2021

FDA gave the nod to Pfizer's Paxlovid | Pfizer to supply 2.5 million doses of Paxlovid to the UK

Germany HTA News | IQWIG and G-BA assessment news | Germany Pharma News

ipharmaservices

Dec 9, 2021

Germany HTA News | IQWIG and G-BA assessment news | Germany Pharma News

European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

ipharmaservices

Nov 21, 2021

European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

NHS England News | NHS to offer Tagrisso for lung cancer patients

ipharmaservices

May 12, 2021

NHS England News | NHS to offer Tagrisso for lung cancer patients

United Kingdom COVID19 News | Has Britain reached herd immunity?

ipharmaservices

May 11, 2021

United Kingdom COVID19 News | Has Britain reached herd immunity?

European Commission approved Benlysta for active lupus nephritis

ipharmaservices

May 9, 2021

European Commission approved Benlysta for active lupus nephritis

France COVID-19 Updates | COVID-19 News in Europe

ipharmaservices

May 4, 2021

France COVID-19 Updates | COVID-19 News in Europe

GSK’s Jemperli received approval in Europe and the US for endometrial cancer

ipharmaservices

Apr 23, 2021

GSK’s Jemperli received approval in Europe and the US for endometrial cancer

England patients to benefit from Phesgo, 5-minute breast cancer treatment from Roche

ipharmaservices

Apr 7, 2021

England patients to benefit from Phesgo, 5-minute breast cancer treatment from Roche

CHMP Opinions | EMA drug approvals

ipharmaservices

Mar 29, 2021

CHMP Opinions | EMA drug approvals

Expected best selling pharmaceutical products (drugs) in 2021

ipharmaservices

Jan 20, 2021

Expected best selling pharmaceutical products (drugs) in 2021

1

2 3

For sponsored articles and advertisements, please write to ipharmaservices@gmail.com

Healthcare Policies

©2022 by ipharmaservices

iPharmaCenter

bottom of page